1,541
Views
12
CrossRef citations to date
0
Altmetric
Review Articles

Decellularized inner body membranes for tissue engineering: A review

ORCID Icon, , , , &
Pages 1287-1368 | Received 10 Apr 2019, Accepted 31 Mar 2020, Published online: 26 Apr 2020

References

  • Langer R, Vacanti J. Tissue engineering. Science. 1993;260(5110):920–926.
  • Gilpin A, Yang Y. Decellularization strategies for regenerative medicine: from processing techniques to applications. Biomed Res Int. 2017;2017:1–13.
  • Lanza R, Langer R, Vacanti JP. Principles of tissue engineering. Massachusetts (USA): Academic press; 2011.
  • Chaudhari A, Vig K, Baganizi D, et al. Future prospects for scaffolding methods and biomaterials in skin tissue engineering: a review. Int J Mol Sci. 2016;17(12):1974.
  • Vats A, Tolley N, Polak J, et al. Scaffolds and biomaterials for tissue engineering: a review of clinical applications. Clin Otolaryngol. 2003;28(3):165–172.
  • Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials. 2006;27(19):3675–3683.
  • Brohem CA, Cardeal LB, Tiago M, et al. Artificial skin in perspective: concepts and applications. Pigment Cell Melanoma Res. 2011;24(1):35–50.
  • Lei P, You H, Andreadis ST. Bioengineered skin substitutes. In: Basu J, Ludlow JW, editors. Organ regeneration. New Jersey (USA): Springer; 2013. p. 267–278.
  • Porzionato A, Stocco E, Barbon S, et al. Tissue-engineered grafts from human decellularized extracellular matrices: a systematic review and future perspectives. Int J Mol Sci. 2018;19(12):4117.
  • Herlihy B. The human body in health and illness. Philadelphia (USA): Elsevier Health Sciences; 2017.
  • Patton KT, Thibodeau GA. Structure & function of the body. Missouri (USA): Elsevier Health Sciences; 2015.
  • Healy JC. Detection of peritoneal metastases. Cancer Imaging. 2001;1(2):4–12.
  • Motedayyen H, Esmaeil N, Tajik N, et al. Method and key points for isolation of human amniotic epithelial cells with high yield, viability and purity. BMC Res Notes. 2017;10(1):552.
  • Li S-T, Yuen D, inventors; Google Patents, assignee. Collagen-coated Tissue-based Membranes patent 13/408,319. 2013.
  • Chopra A, Thomas BS. Amniotic membrane: a novel material for regeneration and repair. J Biomim Biomater Tissue Eng. 2013;18(1):1–8.
  • Cesar Francisco J, Felipe Mogharbel B, Cunha R, et al. 15d-PGJ2-loaded in nanoparticles associated with decellurazied human amniotic membrane scaffold: a potential anti-inflammatory delivery system. Front Nanosci Nanotechnol. 2016;2(2):111–113.
  • Gholipourmalekabadi M, Sameni M, Radenkovic D, et al. Decellularized human amniotic membrane: how viable is it as a delivery system for human adipose tissue-derived stromal cells? Cell Prolif. 2016;49(1):115–121.
  • Gobinathan S, Zainol S, Azizi S, et al. Decellularization and genipin crosslinking of amniotic membrane suitable for tissue engineering applications. J Biomater Sci Polym Ed. 2018;29:2051–2067.
  • Poghosyan T, Gaujoux S, Vanneaux V, et al. In vitro development and characterization of a tissue-engineered conduit resembling esophageal wall using human and pig skeletal myoblast, oral epithelial cells, and biologic scaffolds. Tissue Eng Part A. 2013;19(19-20):2242–2252.
  • Shi P, Gao M, Shen Q, et al. Biocompatible surgical meshes based on decellularized human amniotic membrane. Mater Sci Eng C Mater Biol Appl. 2015;54:112–119.
  • Hasmad H, Yusof MR, Mohd Razi ZR, et al. Human amniotic membrane with aligned electrospun fiber as scaffold for aligned tissue regeneration. Tissue Eng Part C Methods. 2018;24(6):368–378.
  • Shakouri-Motlagh A, O'Connor AJ, Kalionis B, et al. Improved ex vivo expansion of mesenchymal stem cells on solubilized acellular fetal membranes. J Biomed Mater Res. 2019;107(1):232–242.
  • Hortensius RA, Ebens JH, Harley BA. Immunomodulatory effects of amniotic membrane matrix incorporated into collagen scaffolds. J Biomed Mater Res. 2016;104(6):1332–1342.
  • Yang JJ, Jang E-C, Song K-S, et al. The effect of amniotic membrane transplantation on tendon-healing in a rabbit achilles tendon model. Tissue Eng Regen Med. 2010;7(3):323–329.
  • Becker M, Maring JA, Schneider M, et al. Towards a novel patch material for cardiac applications: tissue-specific extracellular matrix introduces essential key features to decellularized amniotic membrane. Int J Mol Sci. 2018;19(4):1032.
  • Francisco JC, Correa Cunha R, Cardoso MA, et al. Decellularized amniotic membrane scaffold as a pericardial substitute: an in vivo study. Transplant Proc. 2016;48(8):2845–2849.
  • Roy R, Haase T, Ma N, et al. Decellularized amniotic membrane attenuates postinfarct left ventricular remodeling. J Surg Res. 2016;200(2):409–419.
  • Amensag S, McFetridge PS. Rolling the human amnion to engineer laminated vascular tissues. Tissue Eng Part C Methods. 2012;18(11):903–912.
  • Amensag S, McFetridge PS. Tuning scaffold mechanics by laminating native extracellular matrix membranes and effects on early cellular remodeling. J Biomed Mater Res. 2014;102(5):1325–1333.
  • Yoshida T, Komaki M, Hattori H, et al. Therapeutic angiogenesis by implantation of a capillary structure constituted of human adipose tissue microvascular endothelial cells. Arterioscler Thromb Vasc Biol. 2010;30(7):1300–1306.
  • Fujisato T, Minatoya K, Yamazaki S, et al. Preparation and recellularization of tissue engineered bioscaffold for heart valve replacement. In: Mori H, Matsuda H, editors. Cardiovascular regeneration therapies using tissue engineering approaches. Japan (Tokyo): Springer; 2005. p. 83–94.
  • Kobayashi A, Miyake H, Hattori H, et al. In vitro formation of capillary networks using optical lithographic techniques. Biochem Biophys Res Commun. 2007;358(3):692–697.
  • Lee O-H, Kim Y-M, Lee YM, et al. Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem Biophys Res Commun. 1999;264(3):743–750.
  • Wang F, Van Brocklyn JR, Hobson JP, et al. Sphingosine 1-phosphate stimulates cell migration through a Gi-coupled cell surface receptor potential involvement in angiogenesis. J Biol Chem. 1999;274(50):35343–35350.
  • Mahmoudi-Rad M, Abolhasani E, Moravvej H, et al. Acellular amniotic membrane: an appropriate scaffold for fibroblast proliferation. Clin Exp Dermatol. 2013;38(6):646–651.
  • Taghiabadi E, Nasri S, Shafieyan S, et al. Fabrication and characterization of spongy denuded amniotic membrane based scaffold for tissue engineering. Cell J. 2015;16(4):13.
  • Gholipourmalekabadi M, Bandehpour M, Mozafari M, et al. Decellularized human amniotic membrane: more is needed for an efficient dressing for protection of burns against antibiotic-resistant bacteria isolated from burn patients. Burns. 2015;41(7):1488–1497.
  • Wilshaw S-P, Kearney JN, Fisher J, et al. Production of an acellular amniotic membrane matrix for use in tissue engineering. Tissue Eng. 2006;12(8):2117–2129.
  • Kshersagar J, Kshirsagar R, Desai S, et al. Decellularized amnion scaffold with activated PRP: a new paradigm dressing material for burn wound healing. Cell Tissue Bank. 2018;19(3):423–436.
  • Sabapathy V, Sundaram B, Vm S, et al. Human Wharton’s jelly mesenchymal stem cells plasticity augments scar-free skin wound healing with hair growth. PloS One. 2014;9(4):e93726.
  • Gholipourmalekabadi M, Seifalian AM, Urbanska AM, et al. 3D protein-based bilayer artificial skin for the guided scarless healing of third-degree burn wounds in vivo. Biomacromolecules. 2018;19(7):2409–2422.
  • Sanluis-Verdes A, Vilar M-P, García-Barreiro JJ, et al. Production of an acellular matrix from amniotic membrane for the synthesis of a human skin equivalent. Cell Tissue Bank. 2015;16(3):411–423.
  • Gholipourmalekabadi M, Samadikuchaksaraei A, Seifalian AM, et al. Silk fibroin/amniotic membrane 3D bi-layered artificial skin. Biomed Mater. 2018;13(3):035003.
  • Song M, Wang W, Ye Q, et al. The repairing of full-thickness skin deficiency and its biological mechanism using decellularized human amniotic membrane as the wound dressing. Mater Sci Eng C Mater Biol Appl. 2017;77:739–747.
  • Ji SZ, Xiao SC, Luo PF, et al. An epidermal stem cells niche microenvironment created by engineered human amniotic membrane. Biomaterials. 2011;32(31):7801–7811.
  • Huang G, Ji S, Luo P, et al. Accelerated expansion of epidermal keratinocyte and improved dermal reconstruction achieved by engineered amniotic membrane. Cell Transplant. 2013;22(10):1831–1844.
  • Minjuan W, Jun X, Shiyun S, et al. Hair follicle morphogenesis in the treatment of mouse full-thickness skin defects using composite human acellular amniotic membrane and adipose derived mesenchymal stem cells. Stem Cells Int. 2016;2016:1–7.
  • Kakabadze Z, Chakhunashvili D, Gogilashvili K, et al. Bone marrow stem cell and decellularized human amniotic membrane for the treatment of nonhealing wound after radiation therapy. Exp Clin Transplant. 2019;17(Suppl 1):92–98.
  • Ajit S, Mallik MA, Fichter Susanne Rieder GB, et al. Fetoscopic closure of punctured fetal membranes with acellular human amnion plugs in a rabbit model. Obstet Gynecol. 2007;110(5):1121–1129.
  • Lee JY, Kim H, Ha DH, et al. Amnion‐analogous medical device for fetal membrane healing: a preclinical long‐term study. Adv Healthcare Mater. 2018;7(18):1800673.
  • Ochsenbein-Kölble N, Jani J, Lewi L, et al. Enhancing sealing of fetal membrane defects using tissue engineered native amniotic scaffolds in the rabbit model. Am J Obstet Gynecol. 2007;196(3): 263.e1–263.e7.
  • Yang SP, Yang XZ, Cao GP. Conjunctiva reconstruction by induced differentiation of human amniotic epithelial cells. Genet Mol Res. 2015;14(4):13823–13834.
  • Liu H, Zhou Z, Lin H, et al. Synthetic nanofiber-reinforced amniotic membrane via interfacial bonding. ACS Appl Mater Interfaces. 2018;10(17):14559–14569.
  • Saghizadeh M, Winkler MA, Kramerov AA, et al. A simple alkaline method for decellularizing human amniotic membrane for cell culture. PLoS One. 2013;8(11):e79632.
  • Sareen D, Saghizadeh M, Ornelas L, et al. Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium. Stem Cells Transl Med. 2014;3(9):1002–1012.
  • Sripriya R, Kumar R. Denudation of human amniotic membrane by a novel process and its characterisations for biomedical applications. Prog Biomater. 2016;5(3-4):161–172.
  • Zhang L, Zou D, Li S, et al. An ultra-thin amniotic membrane as carrier in corneal epithelium. Sci Rep. 2016;6(1):21021.
  • Van den Bogerd B, Ní Dhubhghaill S, Zakaria N. Characterizing human decellularized crystalline lens capsules as a scaffold for corneal endothelial tissue engineering. J Tissue Eng Regen Med. 2018;12(4):e2020–e2028.
  • Fan T, Zhao J, Ma X, et al. Establishment of a continuous untransfected human corneal endothelial cell line and its biocompatibility to denuded amniotic membrane. Mol Vis. 2011;17:469–480.
  • Fan T, Ma X, Zhao J, et al. Transplantation of tissue-engineered human corneal endothelium in cat models. Mol Vis. 2013;19:400.
  • Lim LS, Riau A, Poh R, et al. Effect of dispase denudation on amniotic membrane. Mol Vis. 2009;15:1962–1970.
  • Guo Q, Lu X, Xue Y, et al. A new candidate substrate for cell-matrix adhesion study: the acellular human amniotic matrix. J Biomed Biotechnol. 2012;2012:1–10.
  • Gholipourmalekabadi M, Mozafari M, Salehi M, et al. Development of a cost-effective and simple protocol for decellularization and preservation of human amniotic membrane as a soft tissue replacement and delivery system for bone marrow stromal cells. Adv Healthcare Mater. 2015;4(6):918–926.
  • Salah RA, Mohamed IK, El-Badri N. Development of decellularized amniotic membrane as a bioscaffold for bone marrow-derived mesenchymal stem cells: ultrastructural study. J Mol Hist. 2018;49(3):289–301.
  • Ling L-J, Hung S-L, Lee C-F, et al. The influence of membrane exposure on the outcomes of guided tissue regeneration: clinical and microbiological aspects. J Periodontal Res. 2003;38(1):57–63.
  • Döri F, Huszár T, Nikolidakis D, et al. Effect of platelet‐rich plasma on the healing of intra‐bony defects treated with a natural bone mineral and a collagen membrane. J Clin Periodontol. 2007;34(3):254–261.
  • Li W, Ma G, Brazile B, et al. Investigating the potential of amnion-based scaffolds as a barrier membrane for guided bone regeneration. Langmuir. 2015;31(31):8642–8653.
  • Nogami M, Kimura T, Seki S, et al. A human amnion-derived extracellular matrix-coated cell-free scaffold for cartilage repair: in vitro and in vivo studies. Tissue Eng Part A. 2016;22(7-8):680–688.
  • Karalashvili L, Kakabadze A, Vyshnevska G, et al. Acellular human amniotic membrane as a three-dimensional scaffold for the treatment of mucogingival defects. Georgian Med News. 2015;244–245:84–89.
  • Iwasaki K, Komaki M, Yokoyama N, et al. Periodontal regeneration using periodontal ligament stem cell-transferred amnion. Tissue Eng Part A. 2013;20(3-4):693–704.
  • Chen Y-J, Chung M-C, Yao C-C, et al. The effects of acellular amniotic membrane matrix on osteogenic differentiation and ERK1/2 signaling in human dental apical papilla cells. Biomaterials. 2012;33(2):455–463.
  • Huang C-H, Chen M-H, Young T-H, et al. Interactive effects of mechanical stretching and extracellular matrix proteins on initiating osteogenic differentiation of human mesenchymal stem cells. J Cell Biochem. 2009;108(6):1263–1273.
  • Salasznyk RM, Klees RF, Hughlock MK, et al. Plopper GEJCc, adhesion. ERK signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells on collagen I and vitronectin. Cell Commun Adhes. 2004;11(5-6):137–153.
  • Culligan K, Coffey JC, Kiran RP, et al. The mesocolon: a prospective observational study. Colorectal Dis. 2012;14(4):421–428; discussion 8–30.
  • Coffey JC, O'Leary DP. The mesentery: structure, function, and role in disease. Lancet Gastroenterol Hepatol. 2016;1(3):238–247.
  • Burke JP, Cunningham MF, Watson RW, et al. Bacterial lipopolysaccharide promotes profibrotic activation of intestinal fibroblasts. Br J Surg. 2010;97(7):1126–1134.
  • Burke JP, Watson RW, Mulsow JJ, et al. Endoglin negatively regulates transforming growth factor beta1-induced profibrotic responses in intestinal fibroblasts. Br J Surg. 2010;97(6):892–901.
  • Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, et al. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn’s disease. Gut. 2012;61(1):78–85.
  • Glentis A, Oertle P, Mariani P, et al. Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane. Nat Commun. 2017;8(1):924.
  • Nowocin AK, Southgate A, Shurey S, et al. The development and implantation of a biologically derived allograft scaffold. J Tissue Eng Regen Med. 2016;10(2):140–148.
  • Li Q, Huang C, Xu Z, et al. The fetal porcine aorta and mesenteric acellular matrix as small-caliber tissue engineering vessels and microvasculature scaffold. Aesth Plast Surg. 2013;37(4):822–832.
  • Buyukdogan K, Doral MN, Bilge O, et al. Peritoneum and omentum are natural reservoirs for chondrocytes of osteochondral autografts: A comparative animal study. Acta Orthop Traumatol Turc. 2016;50(5):539–543.
  • Platell C, Cooper D, Papadimitriou JM, et al. The omentum. World J Gastroenterol. 2000;6(2):169–176.
  • Lago G. A complex ECM 3D scaffold with vascular channels by decellularization of human and rat omentum. Plast Reconstr Surg. 2012;130(2S):1.
  • Shevach M, Soffer-Tsur N, Fleischer S, et al. Fabrication of omentum-based matrix for engineering vascularized cardiac tissues. Biofabrication. 2014;6(2):024101.
  • Shevach M, Fleischer S, Shapira A, et al. Gold nanoparticle-decellularized matrix hybrids for cardiac tissue engineering. Nano Lett. 2014;14(10):5792–5796.
  • Soffer-Tsur N, Shevach M, Shapira A, et al. Optimizing the biofabrication process of omentum-based scaffolds for engineering autologous tissues. Biofabrication. 2014;6(3):035023.
  • Porzionato A, Sfriso MM, Macchi V, et al. Decellularized omentum as novel biologic scaffold for reconstructive surgery and regenerative medicine. Eur J Histochem. 2013;57(1):e4.
  • Porzionato A, Sfriso MM, Macchi V, et al. Decellularization of rat and human omentum to develop novel scaffolds to be recellularized with adipose derived stem cells. Ital J Anat Embryol. 2011;116(1):149.
  • Spodick DH. The normal and diseased pericardium: current concepts of pericardial physiology, diagnosis and treatment. J Am Coll Cardiol. 1983;1(1):240–251.
  • Watkins MW, LeWinter MM. Physiologic role of the normal pericardium. Annu Rev Med. 1993;44(1):171–180.
  • Ghazanfari S, Driessen-Mol A, Bouten CV, et al. Modulation of collagen fiber orientation by strain-controlled enzymatic degradation. Acta Biomater. 2016;35:118–126.
  • Wong ML, Wong JL, Athanasiou KA, et al. Stepwise solubilization-based antigen removal for xenogeneic scaffold generation in tissue engineering. Acta Biomater. 2013;9(5):6492–6501.
  • Wong ML, Leach JK, Athanasiou KA, et al. The role of protein solubilization in antigen removal from xenogeneic tissue for heart valve tissue engineering. Biomaterials. 2011;32(32):8129–8138.
  • Mendoza-Novelo B, Alvarado-Castro DI, Mata-Mata JL, et al. Stability and mechanical evaluation of bovine pericardium cross-linked with polyurethane prepolymer in aqueous medium. Mater Sci Eng C Mater Biol Appl. 2013;33(4):2392–2398.
  • Mendoza-Novelo B, Avila EE, Cauich-Rodriguez JV, et al. Decellularization of pericardial tissue and its impact on tensile viscoelasticity and glycosaminoglycan content. Acta Biomater. 2011;7(3):1241–1248.
  • Mendoza-Novelo B, Mata-Mata JL, Vega-González A, et al. Synthesis and characterization of protected oligourethanes as crosslinkers of collagen-based scaffolds. J Mater Chem B. 2014;2(19):2874–2882.
  • Hulsmann J, Grun K, El Amouri S, et al. Transplantation material bovine pericardium: biomechanical and immunogenic characteristics after decellularization vs. glutaraldehyde-fixing. Xenotransplantation. 2012;19(5):286–297.
  • Grebenik EA, Istranov LP, Istranova EV, et al. Chemical cross‐linking of xenopericardial biomeshes: A bottom‐up study of structural and functional correlations. Xenotransplantation. 2019;26(3):e12506.
  • Bielli A, Bernardini R, Varvaras D, et al. Characterization of a new decellularized bovine pericardial biological mesh: Structural and mechanical properties. J Mech Behav Biomed Mater. 2018;78:420–426.
  • Yang M, Chen CZ, Wang XN, et al. Favorable effects of the detergent and enzyme extraction method for preparing decellularized bovine pericardium scaffold for tissue engineered heart valves. J Biomed Mater Res. 2009;91B(1):354–361.
  • Suvaneeth P, Divakaran N, Ramachandra U, et al. In-vitro characterization of differently processed decellularised bovine pericardium. J Livestock Sci. 2016;7:13–18.
  • Umashankar P, Arun T, Kumari T. Short duration gluteraldehyde cross linking of decellularized bovine pericardium improves biological response. J Biomed Mater Res. 2011;97A(3):311–320.
  • Roosens A, Somers P, De Somer F, et al. Impact of detergent-based decellularization methods on porcine tissues for heart valve engineering. Ann Biomed Eng. 2016;44(9):2827–2839.
  • Mirsadraee S, Wilcox HE, Korossis SA, et al. Development and characterization of an acellular human pericardial matrix for tissue engineering. Tissue Eng. 2006;12(4):763–773.
  • Mirsadraee S, Wilcox HE, Watterson KG, et al. Biocompatibility of acellular human pericardium. J Surg Res. 2007;143(2):407–414.
  • Liu ZZ, Wong ML, Griffiths LG. Effect of bovine pericardial extracellular matrix scaffold niche on seeded human mesenchymal stem cell function. Sci Rep. 2016;6(1):37089.
  • Galla S, Mathapati S, Nayak VM, et al. Analytical study to evaluate the extracellular matrix in processed acellular xenografts. Indian J Thorac Cardiovasc Surg. 2010;26(2):132–138.
  • Jahnavi S, Kumary T, Bhuvaneshwar G, et al. Engineering of a polymer layered bio-hybrid heart valve scaffold. Mater Sci Eng C Mater Biol Appl. 2015;51:263–273.
  • Oswal D, Korossis S, Mirsadraee S, et al. Biomechanical characterization of decellularized and cross-linked bovine pericardium. J. Heart Valve Dis. 2007;16(2):165–174.
  • Mathapati S, Bishi DK, Guhathakurta S, et al. Biomimetic acellular detoxified glutaraldehyde cross-linked bovine pericardium for tissue engineering. Mater Sci Eng C Mater Biol Appl. 2013;33(3):1561–1572.
  • Ariganello MB, Labow RS, Lee JM. In vitro response of monocyte‐derived macrophages to a decellularized pericardial biomaterial. J Biomed Mater Res A. 2010;93(1):280–288.
  • Mendoza-Novelo B, González-García G, Mata-Mata JL, et al. A biological scaffold filled with silica and simultaneously crosslinked with polyurethane. Mater Lett. 2013;106:369–372.
  • Zhu D, Jin L, Wang X, et al. Combined anticalcification treatment of bovine pericardium with decellularization and hyaluronic acid derivative. Biomed Mater Eng. 2014;24(1):741–749.
  • Kim M-S, Lim H-G, Kim YJ. Calcification of decellularized and alpha-galactosidase-treated bovine pericardial tissue in an alpha-Gal knock-out mouse implantation model: comparison with primate pericardial tissue. Eur J Cardiothorac Surg. 2016;49(3):894–900.
  • Vinci MC, Tessitore G, Castiglioni L, et al. Mechanical compliance and immunological compatibility of fixative-free decellularized/cryopreserved human pericardium. PLoS One. 2013;8(5):e64769.
  • Pompilio G, Polvani G, Piccolo G, et al. Six-year monitoring of the donor-specific immune response to cryopreserved aortic allograft valves: implications with valve dysfunction. Ann Thorac Surg. 2004;78(2):557–563.
  • Zouhair S, Aguiari P, Iop L, et al. Preservation strategies for decellularized pericardial scaffolds for off-the-shelf availability. Acta Biomater. 2019;84:208–221.
  • Li N, Li Y, Gong D, et al. Efficient decellularization for bovine pericardium with extracellular matrix preservation and good biocompatibility. Interact Cardiovasc Thorac Surg. 2018;26(5):768–776.
  • Lim H-G, Choi SY, Yoon EJ, et al. In vivo efficacy of alpha-galactosidase as possible promise for prolonged durability of bioprosthetic heart valve using alpha1, 3-galactosyltransferase knockout mouse. Tissue Eng Part A. 2013;19(21-22):2339–2348.
  • Min B-J, Kim YJ, Choi J-W, et al. Histologic characteristics and mechanical properties of bovine pericardium treated with decellularization and α-galactosidase: a comparative study. Korean J Thorac Cardiovasc Surg. 2012;45(6):368.
  • Fidalgo C, Iop L, Sciro M, et al. A sterilization method for decellularized xenogeneic cardiovascular scaffolds. Acta Biomater. 2018;67:282–294.
  • Cigliano A, Gandaglia A, Lepedda AJ, et al. Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium. Biochem Res Int. 2012;2012:1–10.
  • Neethling WM, Glancy R, Hodge AJ. Mitigation of calcification and cytotoxicity of a glutaraldehyde-preserved bovine pericardial matrix: improved biocompatibility after extended implantation in the subcutaneous rat model. J Heart Valve Dis. 2010;19(6):778–785.
  • Mathapati S, Bishi DK, Venugopal JR, et al. Nanofibers coated on acellular tissue-engineered bovine pericardium supports differentiation of mesenchymal stem cells into endothelial cells for tissue engineering. Nanomedicine. 2014;9(5):623–634.
  • Wang X, Wang K, Zhang W, et al. A bilaminated decellularized scaffold for islet transplantation: structure, properties and functions in diabetic mice. Biomaterials. 2017;138:80–90.
  • Megerle K, Woon C, Kraus A, et al. Flexor tendon sheath engineering using decellularized porcine pericardium. Plast Reconstr Surg. 2016;138(4):630e–641e.
  • Pagoulatou E, Triantaphyllidou I-E, Vynios DH, et al. Biomechanical and structural changes following the decellularization of bovine pericardial tissues for use as a tissue engineering scaffold. J Mater Sci Mater Med. 2012;23(6):1387–1396.
  • Seif-Naraghi SB, Salvatore MA, Schup-Magoffin PJ, et al. Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering. Tissue Eng Part A. 2010;16(6):2017–2027.
  • Neethling W, Yadav S, Hodge AJ, et al. Enhanced biostability and biocompatibility of decellularized bovine pericardium, crosslinked with an ultra-low concentration monomeric aldehyde and treated with ADAPT. J Heart Valve Dis. 2008;17(4):456–463; discussion 64.
  • Jalili ‐Firoozinezhad S, Rajabi ‐Zeleti S, Marsano A, et al. Influence of decellularized pericardium matrix on the behavior of cardiac progenitors. J Appl Polym Sci. 2016;133(14).
  • van Steenberghe M, Schubert T, Guiot Y, et al. Enhanced vascular biocompatibility of decellularized xeno-/allogeneic matrices in a rodent model. Cell Tissue Bank. 2017;18(2):249–262.
  • Salameh A, Greimann W, Vondrys D, et al., editors. Calcification or not. This is the question. A 1-year study of bovine pericardial vascular patches (CardioCel) in minipigs. Seminars in thoracic and cardiovascular surgery. Elsevier; 2018.
  • Tran HLB, Dinh TTH, Nguyen MTN, et al. Preparation and characterization of acellular porcine pericardium for cardiovascular surgery. Turk J Biol. 2016;40(6):1243–1250.
  • Prat-Vidal C, Galvez-Monton C, Puig-Sanvicens V, et al. Online monitoring of myocardial bioprosthesis for cardiac repair. Int J Cardiol. 2014;174(3):654–661.
  • Galvez-Monton C, Bragos R, Soler-Botija C, et al. Noninvasive assessment of an engineered bioactive graft in myocardial infarction: impact on cardiac function and scar healing. Stem Cells Transl Med. 2017;6(2):647–655.
  • Galvez-Monton C, Fernandez-Figueras MT, Marti M, et al. Neoinnervation and neovascularization of acellular pericardial-derived scaffolds in myocardial infarcts. Stem Cell Res Ther. 2015;6(1):108.
  • Rajabi-Zeleti S, Jalili-Firoozinezhad S, Azarnia M, et al. The behavior of cardiac progenitor cells on macroporous pericardium-derived scaffolds. Biomaterials. 2014;35(3):970–982.
  • Seif-Naraghi S, Singelyn J, DeQuach J, et al. Fabrication of biologically derived injectable materials for myocardial tissue engineering. J Vis Exp. 2010;46.
  • Wang Y, Zhang J, Qin Z, et al. Preparation of high bioactivity multilayered bone-marrow mesenchymal stem cell sheets for myocardial infarction using a 3D-dynamic system. Acta Biomater. 2018;72:182–195.
  • Kajbafzadeh A-M, Tafti SHA, Khorramirouz R, et al. Evaluating the role of autologous mesenchymal stem cell seeded on decellularized pericardium in the treatment of myocardial infarction: an animal study. Cell Tissue Bank. 2017;18(4):527–538.
  • Ghodsizad A, Bordel V, Wiedensohler H, et al. Magnetically guided recellularization of decellularized stented porcine pericardium-derived aortic valve for TAVI. ASAIO J. 2014;60(5):582–586.
  • Santoro R, Consolo F, Spiccia M, et al. Feasibility of pig and human‐derived aortic valve interstitial cells seeding on fixative‐free decellularized animal pericardium. J Biomed Mater Res. 2016;104(2):345–356.
  • Tedder ME, Liao J, Weed B, et al. Stabilized collagen scaffolds for heart valve tissue engineering. Tissue Eng Part A. 2009;15(6):1257–1268.
  • Choe JA, Jana S, Tefft BJ, et al. Biomaterial characterization of off‐the‐shelf decellularized porcine pericardial tissue for use in prosthetic valvular applications. J Tissue Eng Regen Med. 2018;12(7):1608–1620.
  • Amadeo F, Boschetti F, Polvani G, et al. Aortic valve cell seeding into decellularized animal pericardium by perfusion‐assisted bioreactor. J Tissue Eng Regen Med. 2018;12(6):1481–1493.
  • Yang M, Chen CZ, Shu YS, et al. Preseeding of human vascular cells in decellularized bovine pericardium scaffold for tissue-engineered heart valve: an in vitro and in vivo feasibility study. J Biomed Mater Res. 2012;100B(6):1654–1661.
  • Dohmen PM, da Costa F, Lopes SV, et al. Successful implantation of a decellularized equine pericardial patch into the systemic circulation. Med Sci Monit Basic Res. 2014;20:1–8.
  • Dohmen P, da Costa F, Yoshi LS, et al. An experimental study of decellularized xenografts implanted into the aortic position with 4 months of follow up. J Clin Exp Cardiolog. 2012;s4:4–2.
  • Scholl FG, Boucek MM, Chan KC, et al. Preliminary experience with cardiac reconstruction using decellularized porcine extracellular matrix scaffold: human applications in congenital heart disease. World J Pediatr Congenit Heart Surg. 2010;1(1):132–136.
  • Ariganello MB, Labow RS, Lee JM. Response of macrophage-like U937 cells to decellularized tissue heart valve materials. J Heart Valve Dis. 2009;18(2):187–197.
  • Wong ML, Wong JL, Vapniarsky N, et al. In vivo xenogeneic scaffold fate is determined by residual antigenicity and extracellular matrix preservation. Biomaterials. 2016;92:1–12.
  • Bai M, Zhang T, Ling T, et al. Guided bone regeneration using acellular bovine pericardium in a rabbit mandibular model: in‐vitro and in‐vivo studies. J Periodont Res. 2014;49(4):499–507.
  • Healy J, Reznek R. The peritoneum, mesenteries and omenta: normal anatomy and pathological processes. Eur Radiol. 1998;8(6):886–900.
  • Bonvini S, Albiero M, Ferretto L, et al. The peritoneum as a natural scaffold for vascular regeneration. PLoS One. 2012;7(3):e33557.
  • Tsai P-C, Zhang Z, Florek C, et al. Constructing human skin equivalents on porcine acellular peritoneum extracellular matrix for in vitro irritation testing. Tissue Eng Part A. 2016;22(1-2):111–122.
  • Tsai P-C. Development of three dimensional human skin equivalents based on decellularized extracellular matrices and tyrosine-derived polycarbonate polymers for in-vitro drug screening applications. New Jersey (USA): Rutgers University-Graduate School-New Brunswick; 2016.
  • Su Z, Ma H, Wu Z, et al. Enhancement of skin wound healing with decellularized scaffolds loaded with hyaluronic acid and epidermal growth factor. Mater Sci Eng C Mater Biol Appl. 2014;44:440–448.
  • Wu Z, Tang Y, Fang H, et al. Decellularized scaffolds containing hyaluronic acid and EGF for promoting the recovery of skin wounds. J Mater Sci Mater Med. 2015;26(1):59.
  • Heybeli T, Kulacoglu H, Genc V, et al. Basic fibroblast growth factor loaded polypropylene meshes in repair of abdominal wall defects in rats. Chirurgia (Bucur). 2010;105(6):809–816.
  • Wu Z, Fan L, Xu B, et al. Use of decellularized scaffolds combined with hyaluronic acid and basic fibroblast growth factor for skin tissue engineering. Tissue Eng Part A. 2015;21(1-2):390–402.
  • Hoganson DM, Owens GE, O’Doherty EM, et al. Preserved extracellular matrix components and retained biological activity in decellularized porcine mesothelium. Biomaterials. 2010;31(27):6934–6940.
  • Hoganson DM, Owens GE, Meppelink AM, et al. Decellularized extracellular matrix microparticles as a vehicle for cellular delivery in a model of anastomosis healing. J Biomed Mater Res. 2016;104(7):1728–1735.
  • Wood D, Zheng MH. Matrix-induced autologous chondrocyte implantation. In: Williams III RJ, editor. Cartilage repair strategies. New Jersey (USA): Springer. 2007. p. 193–206.
  • Brittberg M. Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix-induced autologous chondrocyte implantation procedure. Am J Sports Med. 2010;38(6):1259–1271.
  • Zheng MH, Hinterkeuser K, Solomon K, et al., editors. Collagen‐derived biomaterials in bone and cartilage repair. Macromolecular symposia. Germany (Weinheim): Wiley Online Library; 2007.
  • Zhang Z, Zhong X, Ji H, et al. Matrix-induced autologous chondrocyte implantation for the treatment of chondral defects of the knees in Chinese patients. Drug Des Dev Ther. 2014;8:2439.
  • Nixon A, Rickey E, Butler T, et al. A chondrocyte infiltrated collagen type I/III membrane (MACI® implant) improves cartilage healing in the equine patellofemoral joint model. Osteoarthritis Cartilage. 2015;23(4):648–660.
  • Zheng M-H, Willers C, Kirilak L, et al. Matrix-induced autologous chondrocyte implantation (MACI®): biological and histological assessment. Tissue Eng. 2007;13(4):737–746.
  • Griffin DJ, Bonnevie ED, Lachowsky DJ, et al. Mechanical characterization of matrix-induced autologous chondrocyte implantation (MACI®) grafts in an equine model at 53 weeks. J Biomech. 2015;48(10):1944–1949.
  • Negrini D, Moriondo A. Pleural function and lymphatics. Acta Physiol. 2013;207(2):244–259.
  • Mills PC, Chen Y, Hills YC, et al. Comparison of surfactant lipids between pleural and pulmonary lining fluids. Pulm Pharmacol Ther. 2006;19(4):292–296.
  • Hills BA. Graphite-like lubrication of mesothelium by oligolamellar pleural surfactant. J Appl Physiol. 1992;73(3):1034–1039.
  • Hills BA, Butler BD, Barrow RE. Boundary lubrication imparted by pleural surfactants and their identification. J Appl Physiol. 1982;53(2):463–469.
  • Wang PM, Lai-Fook SJ. Pleural tissue hyaluronan produced by postmortem ventilation in rabbits. Lung. 2000;178(1):1–12.
  • Melo E, Cardenes N, Garreta E, et al. Inhomogeneity of local stiffness in the extracellular matrix scaffold of fibrotic mouse lungs. J Mech Behav Biomed Mater. 2014;37:186–195.
  • Luque T, Melo E, Garreta E, et al. Local micromechanical properties of decellularized lung scaffolds measured with atomic force microscopy. Acta Biomater. 2013;9(6):6852–6859.
  • Cortiella J, Niles J, Cantu A, et al. Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng Part A. 2010;16(8):2565–2580.
  • Nichols JE, Niles J, Riddle M, et al. Production and assessment of decellularized pig and human lung scaffolds. Tissue Eng Part A. 2013;19(17-18):2045–2062.
  • Tsuchiya T, Mendez J, Calle EA, et al. Ventilation-based decellularization system of the lung. Biores Open Access. 2016;5(1):118–126.
  • S TFR. Fascia research II: Basic science and implications for conventional and complementary health care. Amsterdam (The Netherland): Elsevier Press; 2009.
  • Huijing PA. Epimuscular myofascial force transmission: a historical review and implications for new research. International Society of Biomechanics Muybridge Award Lecture, Taipei, 2007. J Biomech. 2009;42(1):9–21.
  • Sclafani AP, McCormick SA, Cocker R. Biophysical and microscopic analysis of homologous dermal and fascial materials for facial aesthetic and reconstructive uses. Arch Facial Plast Surg. 2002;4(3):164–171.
  • Nakamura N, Kimura T, Kishida A. Overview of the development, applications, and future perspectives of decellularized tissues and organs. ACS Biomater Sci Eng. 2017;3(7):1236–1244.
  • Wang L, Johnson JA, Chang DW, et al. Decellularized musculofascial extracellular matrix for tissue engineering. Biomaterials. 2013;34(11):2641–2654.
  • Keane TJ, Londono R, Turner NJ, et al. Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials. 2012;33(6):1771–1781.
  • van Steenberghe M, Schubert T, Bouzin C, et al. Enhanced vascular biocompatibility and remodeling of decellularized and secured xenogeneic/allogeneic matrices in a porcine model. Eur Surg Res. 2018;59(1-2):58–71.
  • Squier CA, Ghoneim S, Kremenak CR. Ultrastructure of the periosteum from membrane bone. J Anat. 1990;171:233–239.
  • Lin Z, Fateh A, Salem DM, et al. Periosteum: biology and applications in craniofacial bone regeneration. J Dent Res. 2014;93(2):109–116.
  • Zhang X, Awad HA, O’Keefe RJ, et al. A perspective: engineering periosteum for structural bone graft healing. Clin Orthop Relat Res. 2008;466(8):1777–1787.
  • Qi Z, Jinhu N, Xianfeng L, et al. Optimization of the periosteal decellularized bioscaffold. Chin J Orthop. 2016;36(12):9.
  • Chen K, Lin XF, Zhang Q, et al. Decellularized periosteum as a potential biologic scaffold for bone tissue engineering. Acta Biomater. 2015;19:46–55.
  • Lin X, Zhao C, Zhu P, et al. Periosteum extracellular-matrix-mediated acellular mineralization during bone formation. Adv Healthcare Mater. 2018;7(4):1700660.
  • Zhang JF, Zhang Q, Chen JX, et al. Preparation and evaluation of tibia- and calvarium-derived decellularized periosteum scaffolds. ACS Biomater Sci Eng. 2017;3(12):3503–3514.
  • Chen K, Ni J, Li J, et al. Preparation and identification of the periosteal decellularized bioscaffold. Acta Anat Sin. 2015;46(2):6.
  • Ye Y, Pang Y, Zhang Z, et al. Decellularized periosteum-covered chitosan globule composite for bone regeneration in rabbit femur condyle bone defects. Macromol Biosci. 2018;18(9):e1700424.
  • Smith MD, Wechalekar MD. The synovium. In Hochberg's Rheumatology, 6th ed. Missouri (USA): Elsevier; 2014. p. 27–32.
  • Smith MD. Suppl 1: the normal synovium. Open Rheumatol J. 2011;5(100):100–106.
  • Reisbig NA, Hussein HA, Pinnell E, et al. Comparison of four methods for generating decellularized equine synovial extracellular matrix. Am J Vet Res. 2016;77(12):1332–1339.
  • Reisbig NA, Hussein HA, Pinnell E, et al. Evaluation of equine synovial-derived extracellular matrix scaffolds seeded with equine synovial-derived mesenchymal stem cells. Am J Vet Res. 2018;79(1):124–133.
  • Kakabadze Z, Mardaleishvili K, Loladze G, et al. Clinical application of decellularized and lyophilized human amnion/chorion membrane grafts for closing post-laryngectomy pharyngocutaneous fistulas. J Surg Oncol. 2016;113(5):538–543.
  • Lim LS, Poh RWY, Riau AK, et al. Biological and ultrastructural properties of acelagraft, a freeze-dried ɣ-irradiated human amniotic membrane. Arch Ophthalmol. 2010;128(10):1303–1310.
  • Steinke M, Dally I, Friedel G, et al. Host-integration of a tissue-engineered airway patch: two-year follow-up in a single patient. Tissue Eng Part A. 2015;21(3-4):573–579.
  • Fedevych O, Yachnik O, Mykychak Y, et al. Procedure with cylinder mitral valve replacement in 49 days old infant. World J Pediatr Congenit Heart Surg. 2018;9(5):587–590.
  • McBride AW, Ellerkmann RM, Bent AE, et al. Comparison of long-term outcomes of autologous fascia lata slings with Suspend Tutoplast fascia lata allograft slings for stress incontinence. Am J Obstet Gynecol. 2005;192(5):1677–1681.
  • Liu X, Li N, Gong D, et al. Comparison of detergent-based decellularization protocols for the removal of antigenic cellular components in porcine aortic valve. Xenotransplantation. 2018;25(2):e12380.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.